再発性多発性硬化症(RMS)治療のグローバル臨床試験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Relapsing Multiple Sclerosis (RMS) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Relapsing Multiple Sclerosis (RMS) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Relapsing Multiple Sclerosis (RMS) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Relapsing Multiple Sclerosis (RMS) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Relapsing Multiple Sclerosis (RMS) Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Relapsing Multiple Sclerosis (RMS) 32
Jun 09, 2014: Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Biogen Idec Inc. 33
Clinical Trial Overview of Biogen Idec Inc. 33
Sanofi 35
Clinical Trial Overview of Sanofi 35
E. Merck KG 36
Clinical Trial Overview of E. Merck KG 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Teva Pharmaceutical Industries Limited 38
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 38
Neurocrine Biosciences, Inc. 39
Clinical Trial Overview of Neurocrine Biosciences, Inc. 39
Receptos, Inc. 40
Clinical Trial Overview of Receptos, Inc. 40
F. Hoffmann-La Roche Ltd. 41
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 41
Antisense Therapeutics Limited 42
Clinical Trial Overview of Antisense Therapeutics Limited 42
AB Science 43
Clinical Trial Overview of AB Science 43
Clinical Trial Overview of Top Institutes / Government 44
Rocky Mountain Multiple Sclerosis Center 44
Clinical Trial Overview of Rocky Mountain Multiple Sclerosis Center 44
Tehran University of Medical Sciences 45
Clinical Trial Overview of Tehran University of Medical Sciences 45
Charite – Universitatsmedizin Berlin 46
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 46
University at Buffalo 47
Clinical Trial Overview of University at Buffalo 47
Mount Sinai Hospital 48
Clinical Trial Overview of Mount Sinai Hospital 48
The Cleveland Clinic 49
Clinical Trial Overview of The Cleveland Clinic 49
University of British Columbia 50
Clinical Trial Overview of University of British Columbia 50
Imperial College London 51
Clinical Trial Overview of Imperial College London 51
University Hospital, Bordeaux 52
Clinical Trial Overview of University Hospital, Bordeaux 52
Hadassah Medical Organization 53
Clinical Trial Overview of Hadassah Medical Organization 53
Five Key Clinical Profiles 54
Appendix 124
Abbreviations 124
Definitions 124
Research Methodology 125
Secondary Research 125
About GlobalData 126
Contact Us 126
Disclaimer 126
Source 126